- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04452630
Cardiovascular Consequences After COVID-19
The CardioPostCovid Study: Cardiovascular Consequences After COVID-19
The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coronavirus.
The lack of characterization of cardiovascular damages linked to Covid-19 could have medium and long-term consequences on the prognosis of patients. This problematic could lead to a second major public health problem linked to Covid-19 and it is therefore crucial to keep monitoring and screening patients at risk.
In this context of emerging infectious diseases, of poorly characterized cardiovascular damages during infection and of absence of data on the long-term evolution of the infection, the investigators propose to carry out a prospective and observational cohort study focused on the evaluation and the systematic cardiovascular follow up of patients who survived an episode of Covid-19, regardless of their cardiovascular profiles.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Franck THUNY, MD
- Email: franck.thuny@ap-hm.fr
Study Locations
-
-
-
Marseille, France, 13005
- Recruiting
- Assistance Publique Hopitaux de Marseille
-
Contact:
- Franck THUNY, MD
- Email: franck.thuny@ap-hm.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
• All adults affiliated to social security attending the post-Covid follow-up consultation, having presented an episode of Covid-19 diagnosed by at least one positive nasopharyngeal RT-PCR test for SARS-Cov-2 and considered recovered.
Exclusion Criteria:
- Age <18 years old
- Major under guardianship or curatorship
- Absence of non-opposition
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Covid 19 Patients
patients having presented an episode of Covid-19 diagnosed by at least one positive nasopharyngeal RT-PCR test for SARS-Cov-2 and considered recovered.
|
Infectious Diseases and Cardiology Clinical Consultations at 1 month and 12 months of recovery from an episode of Covid-19
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of at least one clinical, biological and/or imaging cardiovascular anomaly within 1 month of recovering
Time Frame: 1 month
|
Describe clinical, biological and imaging cardiovascular data 1 month after recovery from an episode of Covid-19
|
1 month
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-36
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Consequences After an Episode of COVID 19
-
Samsun UniversityCompletedLong-term Consequences of COVID-19 InfectionTurkey
-
Hospices Civils de LyonCompletedto Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of PatientsFrance
-
Terra Biological LLCUnknownTreatment of Fatigue After Resolution of COVID-19 InfectionUnited States
-
Acibadem UniversityCompletedThe Prevalance of HMPV After COVID-19 Pandemic | The Importance of Accurate Diagnosis for HPMVTurkey
-
IRCCS San RaffaeleCompletedPatients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failureItaly
-
Jonathann Kuo, MDActive, not recruitingSARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisCOVIREIVACActive, not recruitingAdult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second DoseFrance
-
University of CalgaryNot yet recruitingPostural Orthostatic Tachycardia Syndrome | Post Acute Sequelae of SARS CoV 2 Infection
-
Assistance Publique - Hôpitaux de ParisGroupe Hospitalier Pitie-SalpetriereTerminatedHistory of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 InfectionFrance
-
University of Lagos, NigeriaUnknown
Clinical Trials on Infectious Disease and Cardiology Clinical Consultations
-
Roswell Park Cancer InstituteCompletedMalignant Female Reproductive System NeoplasmUnited States
-
University of WashingtonMakerere University; Accordia Global Health FoundationCompletedCapacity Building | Support for Midlevel Health Professionals | Diagnostic TrainingUganda
-
Henri Mondor University HospitalCompletedPatients Receiving Antimicrobial TherapyFrance
-
Henri Mondor University HospitalCompletedPatients Under Antimicrobial TherapyFrance
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingPulmonary Arterial HypertensionChina
-
Frederiksberg University HospitalWithdrawnArthritis, Rheumatoid | TelerehabilitationDenmark, Czechia, United Kingdom
-
Hackensack Meridian HealthTerminatedParkinson DiseaseUnited States
-
University Hospital, BordeauxRecruitingParkinson's Disease | Multiple System Atrophy | Progressive Supranuclear Palsy | Parkinsonian SyndromesFrance
-
Dr. Rebecca SchuleGerman Federal Ministry of Education and Research; German Center for Neurodegenerative...RecruitingHereditary Spastic ParaplegiaAustria, Germany, Italy
-
Prof. Dr. Matthis SynofzikRecruitingAtaxiaGermany, Italy, Australia, Brazil, France, New Zealand, Turkey